ITGA5 and triple-negative breast carcinoma: In this respect, ITGA5 silencing in Hs578T cells (a triple-negative breast cancer cell line expressing high ITGA5 levels) recapitulates inhibitory effects of miR-30s on bone metastasis formation in vivo [40].